Investors Buy up Stocks in Biggest Follow-on Offering Day in Biotech History
December 11, 2025
Endpoints News is calling December 10 the busiest day ever in biotech, with the most follow-on proceeds in a single day. A record-setting $3.2B in biotech follow-on stock offerings were sold, indicating public investors’ appetite for biotech investment. From late Tuesday evening into Wednesday morning, eight biotechs priced sales of new stocks, and seven of those companies increased their offering sizes to meet demand.
Utah’s own Denali Therapeutics was among the biotechs raising funds.
Recent News
- Rep. Celeste Maloy Tours BIOS, Neurotech Innovation
- U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam for Pediatric Patients with Tourette Syndrome
- Sera Prognostics Appoints Scott Gleason CFO
- Merit Medical Announces Global Operations Leadership Transition
- Utah Life Sciences Innovation Caucus Breakfast
- Curavit Expands Clinical Research Capabilities with Acquisition of Lindus Health CRO Assets, Accelerating Global Trial Execution for Life Science Sponsors
